Back to search

Georgia Institute of Technology

Engineering the pregnane X receptor and estrogen receptor alpha to bind novel small molecules using negative chemical complementation

Abstract

dc:description.abstract

Nuclear receptors are ligand-activated transcription factors that play significant roles in various biological processes within the body, such as cell development, hormone metabolism, reproduction, and cardiac function. As transcription factors, nuclear receptors are involved in many diseases, such as diabetes, cancer, and arthritis, resulting in approximately 10-15% of the pharmaceutical drugs presently on the market being targeted toward nuclear receptors. Structurally, nuclear receptors consist of a DNA-binding domain (DBD), responsible for binding specific sequences of DNA called response elements, fused to a ligand-binding domain (LBD) through a hinge region. The LBD binds a small molecule ligand. Upon ligand binding, the LBD changes to an active conformation leading to the recruitment of coactivator (CoAC) proteins and initiation of transcription. As a result of their involvement in disease, there is an emphasis on engineering nuclear receptors for applications in gene therapy, drug discovery and metabolic engineering.

Degree

thesis:*
Department dc:contributor.department
Chemistry and Biochemistry
Grantor dc:publisher
Georgia Institute of Technology
Year dc:date.issued
2011

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Shaffer, Hally A.
Advisors dc:contributor.advisor
  • Azizi, Bahareh
  • Doyle, Donald F.
  • Bommarius, Andreas S.
  • Williams, Loren D.
Committee members dc:contributor.committeemember
  • Oyelere, Adegboyega
  • Nick Hud
  • May, Sheldon W.

Subjects

dc:subject × 11

Identifiers

dc:identifier.*
Handle dc:identifier.uri
http://hdl.handle.net/1853/39620

Chain of custody

source
Harvested from
Georgia Tech
Base URL
repository.gatech.edu/server/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Shaffer, Hally A.. Engineering the pregnane X receptor and estrogen receptor alpha to bind novel small molecules using negative chemical complementation. Georgia Institute of Technology, 2011. http://hdl.handle.net/1853/39620